NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

Esomeprazole的全球市場:2020-2026年

Global Esomeprazole Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 949518
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Esomeprazole的全球市場:2020-2026年 Global Esomeprazole Market 2020-2026
出版日期: 2020年06月03日內容資訊: 英文
簡介

預計在2020年至2026年的預測期內,全球Esomeprazole市場將呈現溫和增長。Esomeprazole首先由美國食品藥品監督管理局(FDA)以阿斯利康(AstraZeneca plc)的Nexium品牌批准。胃食管反流病(GERD)的高發病率是全球市場增長的主要推動力之一。2017年,在美國,僅Esomeprazole的處方便約為900萬次。但是,自2011年以來,處方數量持續下降。Esomeprazole的替代品的存在是市場增長的主要限制之一。Omeprazole是Esomeprazole的化學異構體,是Esomeprazole的最常見替代品之一。

本報告提供全球Esomeprazole市場相關調查分析,提供市場概要,市場成長的影響要素,市場規模與預測,各市場區隔的市場分析,各地各國的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 報告概要

第2章 市場概要及考察

  • 調查範圍
  • 分析師的考察&目前市場趨勢
  • 法律規則

第3章 競爭情形

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析
    • AbbVie Inc
    • Sanofi SA
    • Mylan NV
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 機會

第5章 市場區隔

  • 全球Esomeprazole市場:各疾病
    • 糜爛性食管炎
    • 胃食道逆流症
    • 幽門螺桿菌菌感染疾病
    • 其他
  • 全球Esomeprazole市場:各類型
    • 品牌醫藥品
    • 學名藥
  • 全球Esomeprazole市場:各投藥類型
    • 膠囊·錠劑
    • 注射
    • 其他(懸吊系統/懸浮液)

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • Alkem Laboratories Ltd.
  • AstraZeneca plc
  • Aurobindo Pharma Ltd.
  • Cadila Healthcare Ltd.
  • Chongqing LUMMY Pharmaceutical Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Inc.
  • Grunenthal GmbH
  • Laboratorios Saval S.A.
  • Lannett Co., Inc.
  • Mylan N.V
  • Novartis AG (Sandoz)
  • Sanofi SA
  • Stada Arzneimittel AG
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
目錄
Product Code: OMR2021837

Global Esomeprazole Market Size, Share & Trends Analysis Report, By Disease (Erosive Esophagitis, Gastroesophageal Reflux Disease, Helicobacter Pylori Infection, Other), By Type (Branded and Generic), By Dosage Type (Capsules & Tablets, Injections, and Other) and Forecast, 2020-2026

The global esomeprazole market is anticipated to show a modest growth rate during the forecast period 2020-2026. Esomeprazole was first approved by the US FDA to AstraZeneca plc under the brand name Nexium. High incidences of gastroesophageal reflux disease (GERD) is one of the major factors for the growth of the market all across the globe. In 2017, esomeprazole was prescribed around 9 million times alone in the US. However, prescription numbers are reducing continuously since 2011. The presence of alternative drugs of esomeprazole is one of the major restraining factors for market growth. Omeprazole, a chemical isomer of esomeprazole is one of the most common alternatives of esomeprazole.

The global esomeprazole market is segmented based on disease, type, and dosage type. By disease, the market is further segmented into erosive esophagitis, gastroesophageal reflux disease, helicobacter pylori infection, and others. By type, the market is bifurcated into branded and generic drugs. Significant growth in the generic drug market will be witnessed during the forecast period all across the globe. By dosage type, the market is segmented into capsules & tablets, injections, and others. Capsules & tablets are expected to have a major market share during the forecast period.

By geography, the global esomeprazole market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to hold a considerable market share. However, significant major market growth will be witnessed in Asia-Pacific due to significant revenue generation of Nexium in Japan and China.

The esomeprazole market is consolidated in nature and a few major market players are operating in the market. Some of the major market players include AbbVie Inc, Sanofi SA, Mylan NV, Novartis AG, Teva Pharmaceutical Industries Ltd., Grunenthal GmbH, Glenmark Pharmaceuticals Inc., and Mylan N.V. The market players are adopting growth strategies including mergers & acquisitions, product approvals, and partnerships & collaborations to gain a competitive edge in the market.

Research Methodology

The market study of the global esomeprazole market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to breakdown the market in various segments; derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to amplify the added validity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Esomeprazole Market Research and Analysis, By Disease
  • Global Esomeprazole Market Research and Analysis, By Type
  • Global Esomeprazole Market Research and Analysis, By Dosage Type

The Report Covers:

  • Comprehensive research methodology of the Global Esomeprazole Market.
  • A detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Esomeprazole Market.
  • Insights about market determinants which are stimulating the Global Esomeprazole Market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdowns
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. AbbVie Inc
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Sanofi SA
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Mylan NV
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Novartis AG
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Teva Pharmaceutical Industries Ltd.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Esomeprazole Market by Disease
    • 5.1.1. Erosive Esophagitis
    • 5.1.2. Gastroesophageal Reflux Disease
    • 5.1.3. Helicobacter Pylori Infection
    • 5.1.4. Other
  • 5.2. Global Esomeprazole Market by Type
    • 5.2.1. Branded
    • 5.2.2. Generic
  • 5.3. Global Esomeprazole Market by Dosage Type
    • 5.3.1. Capsules & Tablets
    • 5.3.2. Injections
    • 5.3.3. Other ( Suspension)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Alkem Laboratories Ltd.
  • 7.2. AstraZeneca plc
  • 7.3. Aurobindo Pharma Ltd.
  • 7.4. Cadila Healthcare Ltd.
  • 7.5. Chongqing LUMMY Pharmaceutical Co., Ltd.
  • 7.6. Dr. Reddy's Laboratories Ltd.
  • 7.7. Glenmark Pharmaceuticals Inc.
  • 7.8. Grunenthal GmbH
  • 7.9. Laboratorios Saval S.A.
  • 7.10. Lannett Co., Inc.
  • 7.11. Mylan N.V
  • 7.12. Novartis AG (Sandoz)
  • 7.13. Sanofi SA
  • 7.14. Stada Arzneimittel AG
  • 7.15. Sun Pharmaceutical Industries Ltd.
  • 7.16. Teva Pharmaceutical Industries Ltd.

LIST OF TABLES

  • 1. GLOBAL ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY DISEASE, 2019-2026 ($ MILLION)
  • 2. GLOBAL EROSIVE ESOPHAGITIS MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 4. GLOBAL HELICOBACTER PYLORI INFECTION MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 5. GLOBAL OTHER DISEASE MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 6. GLOBAL ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 7. GLOBAL BRANDED ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 8. GLOBAL GENERIC ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 9. GLOBAL ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2019-2026 ($ MILLION)
  • 10. GLOBAL CAPSULES & TABLETS MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 11. GLOBAL INJECTIONS MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 12. GLOBAL OTHER DOSAGE TYPE MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 13. NORTH AMERICAN ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 14. NORTH AMERICAN ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY DISEASE, 2019-2026 ($ MILLION)
  • 15. NORTH AMERICAN ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 16. NORTH AMERICAN ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2019-2026 ($ MILLION)
  • 17. EUROPEAN ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 18. EUROPEAN ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY DISEASE, 2019-2026 ($ MILLION)
  • 19. EUROPEAN ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 20. EUROPEAN ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2019-2026 ($ MILLION)
  • 21. ASIA PACIFIC ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 22. ASIA PACIFIC ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY DISEASE, 2019-2026 ($ MILLION)
  • 23. ASIA PACIFIC ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 24. ASIA PACIFIC ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2019-2026 ($ MILLION)
  • 25. REST OF THE WORLD ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY DISEASE, 2019-2026 ($ MILLION)
  • 26. REST OF THE WORLD ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 27. REST OF THE WORLD ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ESOMEPRAZOLE MARKET SHARE BY DISEASE, 2019 VS 2026 (%)
  • 2. GLOBAL ESOMEPRAZOLE MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 3. GLOBAL ESOMEPRAZOLE MARKET SHARE BY DOSAGE TYPE, 2019 VS 2026 (%)
  • 4. GLOBAL ESOMEPRAZOLE MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 5. US ESOMEPRAZOLE MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. CANADA ESOMEPRAZOLE MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. UK ESOMEPRAZOLE MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. FRANCE ESOMEPRAZOLE MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. GERMANY ESOMEPRAZOLE MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. ITALY ESOMEPRAZOLE MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. SPAIN ESOMEPRAZOLE MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. REST OF EUROPE ESOMEPRAZOLE MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. INDIA ESOMEPRAZOLE MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. CHINA ESOMEPRAZOLE MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. JAPAN ESOMEPRAZOLE MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC ESOMEPRAZOLE MARKET SIZE, 2019-2026 ($ MILLION)